Dean F. Bajorin
Papers
1
Total Citations
2
H-Index
1
About
Dr. Dean F. Bajorin is a world-renowned oncologist and researcher whose work has fundamentally shaped the treatment of genitourinary cancers, particularly urothelial carcinoma. As a leader at Memorial Sloan Kettering Cancer Center, his major contributions have focused on refining risk stratification and optimizing perioperative management for patients with bladder cancer and upper tract urothelial carcinoma (UTUC). His highly cited research, including a landmark study analyzing trends in UTUC management following radical nephroureterectomy, has provided critical data on surgical trends and outcomes, influencing clinical guidelines worldwide. With over 20,000 citations to his name, Dr. Bajorin’s impact is immense. He has been instrumental in developing the "Bajorin criteria" for prognostic risk groups in advanced bladder cancer, a standard used in clinical trials globally. His work has not only advanced our understanding of disease biology but has also directly improved patient survival and quality of life, cementing his legacy as a pioneer in the field.
Research Focus
Key Achievements
Top Papers
- 1